Animal models of cholangiocarcinoma: What they teach us about the human disease - 10/05/18
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Summary |
Despite recent advances, pathogenesis of cholangiocarcinoma, a highly lethal cancer, remains enigmatic. Furthermore, treatment options are still limited and often disappointing. For this reason, in the last few years there has been a mounting interest towards the generation of experimental models able to reproduce the main features associated with this aggressive behavior. Toxic and infestation-induced, genetically engineered and cell implantation rodent models have been generated, contributing to a deeper understanding of the complex cell biology of the tumor, sustained by multiple cell interactions and driven by a huge variety of molecular perturbations. Herein, we will overview the most relevant animal models of biliary carcinogenesis, highlighting the methodological strategy, the molecular, histological and clinical phenotypes consistent with the human condition, their particular strengths and weaknesses and the novel therapeutic approaches that have been developed.
Le texte complet de cet article est disponible en PDF.Keywords : Genetically engineered mouse models, Toxic models, Xenotransplantation, Syngeneic models, Primary liver cancer
Abbreviations : Alb-Cre, BDL, BET, CCA, CCl4, CYP, DEN, EGFR, EGFP, eNOS, ER, ERK, GFP, GEMM, HCC, HGF, IDH, IL, iNOS, YAP, KRAS, LMBD, MMP, MNT, MUC, NK, NDMAN, NOD, PDX, PTEN, PKA, Prkar1a, SCID, SDS, SMA, SMAD, TAA
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?